Recurrent Pregnancy Loss and IVF


What is recurrent pregnancy loss (RPL)?

The American Society for Reproductive Medicine (ASRM) defines RPL as a condition when a woman has 2 or more clinical pregnancy losses (miscarriages) before the pregnancies reach 20 weeks. Biochemical losses are usually not included in making an RPL diagnosis, but some physicians do take these into account. Pregnancy loss is common, affecting up to 25% of pregnancies, but RPL is rarer, with less than 5% of people experiencing 2 consecutive miscarriages and less than 1% of people experiencing three or more losses. (1)

  • Clinical pregnancy is confirmed by an ultrasound conducted by a healthcare provider, or in the case of a miscarriage by examination of the products of conception.

  • Biochemical pregnancy loss is one that has been detected by urine pregnancy test or blood testing for hCG before then becoming negative.

What are some known causes of RPL?

When would IVF be indicated?

  • IVF may be recommended for RPL due to genetic causes like translocation of chromosomes. Chromosomal translocation is rare, and associated with 2-5% of RPL. IVF allows for preimplantation genetic testing for structural rearrangements (PGT-SR) and the ability to screen embryos for abnormal chromosome number so only those with a normal set of chromosomes will be considered for transfer.  

  • IVF with preimplantation genetic testing for aneuploidy (PGT-A) may also be offered to patients with RPL given the most common cause of loss is abnormal genetics in the embryo. Some retrospective studies have shown improved live birth rates for patients with RPL using PGT-A, but there are no randomized controlled trial showing a benefit.  

  • Otherwise, the management of RPL is patient specific and focuses on trying to identify a cause of RPL specific to that patient that can be treated prior to trying to conceive again.

Last Reviewed: September 21, 2023